In one paragraphArticle in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Tomasz KolendaResearch and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0000-0001-5623-7398 Piotr BiałasDepartment of Cell Biology, Poznan University of Medical Sciences, Rokietnicka 5D, 60-806 Poznan, Poland.ORCID 0000-0001-9133-4177 Paulina PoterLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 15 Garbary Street, 61-866 Poznan, Poland.ORCID 0000-0003-1811-6901 Marlena Janiczek-PolewskaDepartment of Clinical Oncology, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0000-0002-1238-5273 Anna ZapłataDepartment of Laboratory Diagnostics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0009-0002-5611-1853 Kacper GuglasLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 15 Garbary Street, 61-866 Poznan, Poland.ORCID 0000-0002-2296-7808 Patrycja MantajRadiation Protection Department, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0000-0001-5757-9461 Anna PrzybyłaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 15 Garbary Street, 61-866 Poznan, Poland.
Urszula KazimierczakDepartment of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
Ewa LeporowskaDepartment of Laboratory Diagnostics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0000-0001-5193-8697 Zefiryn CybulskiResearch and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
Anna TeresiakResearch and Implementation Unit, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.ORCID 0000-0002-5327-6698 Funding
Greater Poland Cancer Centre 22/02/2024/BAK/WCO/002Greater Poland Cancer Centre 23/09/2024/F/WCO/008.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Adenosine DeaminaseBiomarkers, TumorHead and Neck NeoplasmsRNA-Binding ProteinsSquamous Cell Carcinoma of Head and NeckAdultAgedCell Line, TumorClinical RelevanceFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisTranscriptomeADARB1 protein, humanADAR protein, humanAdenosine DeaminaseBiomarkers, TumorRNA-Binding ProteinsADAR1ADAR2ADAR3biomarkerdeaminase adenosinehead and neck cancersRNA metabolismTCGA
Identifiers
PMID41300768
PMCPMC12652663
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390